يعرض 1 - 10 نتائج من 29 نتيجة بحث عن '"Monika Patre"', وقت الاستعلام: 1.15s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer

    المؤلفون: Edith A. Perez, Sanne Lysbet de Haas, Wolfgang Eiermann, Carlos H. Barrios, Masakazu Toi, Young-Hyuck Im, Pier Franco Conte, Miguel Martin, Tadeusz Pienkowski, Xavier B. Pivot, Howard A. Burris, Sven Stanzel, Monika Patre, Paul Anthony Ellis

    المصدر: BMC Cancer, Vol 19, Iss 1, Pp 1-14 (2019)

    مصطلحات موضوعية: Biomarker, Metastatic breast cancer, HER2, MARIANNE, mRNA, PIK3CA, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: http://link.springer.com/article/10.1186/s12885-019-5687-0Test; https://doaj.org/toc/1471-2407Test

    الوصول الحر: https://doaj.org/article/09e852dddd5a43cfa17d3f82a5431f82Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer

    المؤلفون: Edith A. Perez, Sanne Lysbet de Haas, Wolfgang Eiermann, Carlos H. Barrios, Masakazu Toi, Young-Hyuck Im, Pier Franco Conte, Miguel Martin, Tadeusz Pienkowski, Xavier B. Pivot, Howard A. Burris, Sven Stanzel, Monika Patre, Paul Anthony Ellis

    المصدر: BMC Cancer, Vol 19, Iss 1, Pp 1-2 (2019)

    مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: http://link.springer.com/article/10.1186/s12885-019-5831-xTest; https://doaj.org/toc/1471-2407Test

    الوصول الحر: https://doaj.org/article/690a5325d92f4fad952802d4d744779bTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2–positive advanced breast cancer: Final results from MARIANNE

    المؤلفون: Edith A. Perez, Carlos Barrios, Wolfgang Eiermann, Masakazu Toi, Young‐Hyuck Im, Pierfranco Conte, Miguel Martin, Tadeusz Pienkowski, Xavier B. Pivot, Howard A. Burris, Jennifer A. Petersen, Sanne De Haas, Silke Hoersch, Monika Patre, Paul Anthony Ellis

    مصطلحات موضوعية: Cancer Research, Oncology

    العلاقة: url:https://www.openaccessrepository.it/communities/itmirrorTest; https://www.openaccessrepository.it/record/30872Test

    الإتاحة: https://doi.org/10.1002/cncr.32392Test
    https://www.openaccessrepository.it/record/30872Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    Abstract PS7-23: Neoadjuvant and adjuvant therapy (NAT/AT) treatment patterns and clinical characteristics in a real-world cohort of US patients with HR+/HER2− early breast cancer (eBC)

    المؤلفون: Preet K. Dhillon, Monika Patre, Tanja Badovinac Crnjevic, Christopher Craggs, Mary K. Downer, Frauke Schimmoller, Carlos Flores-Avile, Patricia Luhn, Amie Tan

    المصدر: Cancer Research. 81:PS7-23

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Nat, business.industry, Internal medicine, Cohort, medicine, Adjuvant therapy, business, Early breast cancer

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::71031a8a8016c4369167cce5ad54511eTest
    https://doi.org/10.1158/1538-7445.sabcs20-ps7-23Test


    أضف إلى المفضلة
  5. 5
    Abstract PD5-11: Association of immune gene expression with outcome in the MARIANNE phase 3 clinical trial in HER2-positive metastatic breast cancer (MBC)

    المؤلفون: C. Lambertini, Tadeusz Pienkowski, Silke Hoersch, Monika Patre, Howard A. Burris, Pierfranco Conte, Wolfgang Eiermann, Sanne de Haas, Young Hyuck Im, Miguel Martin, Xavier Pivot, Edith A. Perez, Masakazu Toi, Carlos Barrios, Paul Anthony Ellis

    المصدر: Cancer Research. 80:PD5-11

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, education.field_of_study, Taxane, Proportional hazards model, business.industry, Population, Cancer, Phases of clinical research, medicine.disease, Metastatic breast cancer, Breast cancer, Trastuzumab, Internal medicine, medicine, education, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::d9c980f2e06677b052adf869206c2a63Test
    https://doi.org/10.1158/1538-7445.sabcs19-pd5-11Test


    أضف إلى المفضلة
  6. 6
    Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study

    المؤلفون: Erika Hamilton, Carla I. Falkson, Jacob Rotmensch, Gregory A. Vidal, Stephen Y. Chui, Virginia G. Kaklamani, Patrick J. Ward, Luciana Molinero, Yijin Li, Leisha A. Emens, Monika Patre, Kushagra Gupta

    المصدر: Clinical breast cancer. 21(6)

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Cancer Research, medicine.medical_specialty, Receptor, ErbB-2, medicine.medical_treatment, Antineoplastic Agents, Breast Neoplasms, Docetaxel, Ado-Trastuzumab Emtansine, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Cancer immunotherapy, Trastuzumab, Atezolizumab, Internal medicine, Tumor Microenvironment, Medicine, Humans, skin and connective tissue diseases, neoplasms, business.industry, Cancer, Middle Aged, medicine.disease, Metastatic breast cancer, Neoadjuvant Therapy, 030104 developmental biology, chemistry, Trastuzumab emtansine, 030220 oncology & carcinogenesis, Female, Taxoids, Pertuzumab, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::249e8c43cc1e1819f6fb140a3865b343Test
    https://pubmed.ncbi.nlm.nih.gov/34154926Test


    أضف إلى المفضلة
  7. 7
    Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial

    المؤلفون: Haiying Liu, Sanne de Haas, Seock-Ah Im, Francisco J. Esteva, Jigna Shah, Sherene Loi, Monika Patre, C. Lambertini, Sung Bae Kim, Yifan Wang, Mark Beresford, Aruna Mani, Leisha A. Emens, Roberto Salgado, Cristina Saura, Michelino De Laurentiis

    المساهمون: Emens, L. A., Esteva, F. J., Beresford, M., Saura, C., De Laurentiis, M., Kim, S. -B., Im, S. -A., Wang, Y., Salgado, R., Mani, A., Shah, J., Lambertini, C., Liu, H., de Haas, S. L., Patre, M., Loi, S.

    المصدر: The Lancet. Oncology. 21(10)

    مصطلحات موضوعية: 0301 basic medicine, Male, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Receptor, ErbB-2, Population, Programmed Cell Death 1 Receptor, Phases of clinical research, Breast Neoplasms, Placebo, Ado-Trastuzumab Emtansine, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Antineoplastic Agents, Immunological, Double-Blind Method, Atezolizumab, Trastuzumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, Humans, education, Adverse effect, education.field_of_study, business.industry, Middle Aged, medicine.disease, Metastatic breast cancer, Survival Analysis, 030104 developmental biology, Treatment Outcome, Oncology, chemistry, Trastuzumab emtansine, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Female, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6df8ea55582f078b15ed0a54a5bdc723Test
    https://pubmed.ncbi.nlm.nih.gov/33002436Test


    أضف إلى المفضلة
  8. 8
    persevERA Breast Cancer (BC): Phase III study evaluating the efficacy and safety of giredestrant (GDC-9545) + palbociclib versus letrozole + palbociclib in patients (pts) with estrogen-receptor-positive, HER2-negative locally advanced or metastatic BC (ER+/HER2– LA/mBC)

    المؤلفون: Monika Patre, Ching-Wei Chang, Seock-Ah Im, Sherene Loi, Graham Ross, Komal Jhaveri, Nicholas C. Turner, Aditya Bardia, Meritxell Bellet, Naoki Niikura, Carlos Barrios, Volkmar Mueller, Véronique Diéras

    المصدر: Journal of Clinical Oncology. 39:TPS1103-TPS1103

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Letrozole, HER2 negative, Locally advanced, Estrogen receptor, Palbociclib, medicine.disease, Breast cancer, Internal medicine, Medicine, In patient, business, Adjuvant, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::eb7785f1ff3c256e643c8fc8c2cb12b8Test
    https://doi.org/10.1200/jco.2021.39.15_suppl.tps1103Test


    أضف إلى المفضلة
  9. 9
    acelERA Breast Cancer (BC): Phase II study evaluating efficacy and safety of giredestrant (GDC-9545) versus physician’s choice of endocrine monotherapy in patients (pts) with estrogen receptor-positive, HER2-negative (ER+/HER2-) locally advanced or metastatic breast cancer (LA/mBC)

    المؤلفون: Elgene Lim, Mahesh Shivhare, Monika Patre, Maria Louka, Mariana Chavez-Mac Gregor, Graham Ross, Laura Roncoroni, Joohyuk Sohn, Miguel Martín

    المصدر: Journal of Clinical Oncology. 39:TPS1100-TPS1100

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, HER2 negative, Locally advanced, Estrogen receptor, Phases of clinical research, medicine.disease, Metastatic breast cancer, Breast cancer, Internal medicine, Medicine, Endocrine system, In patient, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7e7310b1b1ec8aabdd6a9e6a2fdbb164Test
    https://doi.org/10.1200/jco.2021.39.15_suppl.tps1100Test


    أضف إلى المفضلة
  10. 10
    LBA15 Primary results from IMpassion131, a double-blind placebo-controlled randomised phase III trial of first-line paclitaxel (PAC) ± atezolizumab (atezo) for unresectable locally advanced/metastatic triple-negative breast cancer (mTNBC)

    المؤلفون: David Cameron, Kenneth Russell, Monika Patre, Vladimir Semiglazov, Leilani Morales, D. Kaen, David Miles, Carlos Barrios, L. Andrade, Andreas Schneeweiss, Mattea Reinisch, B H Xu, Fabrice Andre, Joseph Gligorov, Joyce O'Shaughnessy, Margarita Donica, Andrew M Wardley

    المصدر: Annals of Oncology. 31:S1147-S1148

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, First line, Locally advanced, Hematology, Placebo, Double blind, chemistry.chemical_compound, Paclitaxel, chemistry, Atezolizumab, Internal medicine, medicine, business, Triple-negative breast cancer

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::64a35885eb6a92214532633a3a41a264Test
    https://doi.org/10.1016/j.annonc.2020.08.2243Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث